Skip to content Skip to sidebar Skip to footer

Scientists discover new ways to battle future pandemics

Nathan Boase always knew he would be a scientist, and he is currently researching…

Nathan Boase always knew he would be a scientist, and he is currently researching new methods to protect people against viruses like Monkeypox and COVID-19.

Boase and his team from QuT have been given the green light to develop a new technology that stops emerging viruses from developing and spreading through human cells during future pandemics. 

The team hopes that by ‘attacking’ the envelope of the viruses, they'll be able to block viral particles from merging with human cells and halt their ability to replicate.

“If we can do that, then your immune system will eventually catch up and then kick off the rest of the viruses on the outside of the cells,” Boase told Nursing Review.

“What we're trying to do is reduce the amount of infection, reduce the infection chance and more, by targeting the virus rather than necessarily training the immune system.” 

According to the researcher, most viruses need to fuse with the human cell to be able to develop further and propagate. 

The team will try to use polymer and long chain molecules to target the viral envelope that usually merges with the cell and, in doing so, deactivate the viruses. 

“As long as the virus has an envelope we're hoping that our polymers will be effective against them,” Boase said. 

“We are looking at it on the molecular scale. How can we get these polymer molecules to do this deactivation of the viruses, and how does that work?"

According to Boase, this new technique could target any viruses dangerous to the human race as long as they have a ‘casing’.

“We're targeting the really specific strain areas, it won't just target Influenza, COVID, or Monkeypox. 

“It is an exciting new project. Nobody really looked at this with polymers, and I think there's a natural ability for them to be very effective in this area,” he added.

For as long as he can remember, Boase turned to science to find answers about how the world around him worked. 

It was through university summer research project schemes that he found his niche. By the time he graduated, he had already participated in multiple projects that each contributed to his career.

“The research scheme got me into nanoscience and polymers, and then it gave me the opportunity to participate in a nanomedicine focused project – it has just fascinated me ever since.”

Before venturing into viruses research, Boase had focused on nanomedicines for cancer and antibacterial coatings for infections. 

During the pandemic he rethought his career trajectory and developed the idea to use polymers and nanomedicine to target the viruses envelope. 

Funded by the US Department of Defense via a $US200,000 Discovery grant scheme, the team will have two years to investigate their hypothesis. 

It’s a blessing for Boase, who couldn’t have dreamed of getting that much funding while being in the early stages of his career. 

“All the department is interested in is completely new research ideas, you don't need a track record and you're not competing with people that have 20, 30 years’ worth of papers behind them.

“They're really just interested in getting new ideas back into the scientific literature that might benefit their personnel or their veterans,” Boase said. 

“Which means, this is a brand new area for us too.”

Over the long run, Boase hopes that the research will ‘revolutionise’ antiviral therapeutics goods and prevent future pandemics by helping people that are already affected or even prophylaxis in an area likely to be infected.

“We're hoping it will be like a rapid therapeutic that can be deployed directly and that it'll provide some relief early on when a new viral pandemic emerges that we have no therapy or vaccine for.”

In Australia, the interaction between polymers and virus membranes is a new research area that Boase believes will be beneficial in other medicine and drug delivery, as well as therapeutics and testing. 

In addition to looking at how polymers can deactivate emerging viruses, the QuT team will also have a background focus on inflammation and immune response to viral infections, which will also have a benefit outside of this project directly, Boase said. 

Leave a comment